Regulated Optical coherence tomography Follow-ups for Thrombus Evaluation-01 (ROUTE-01) study
Not Applicable
- Conditions
- patients with coronary artery disease referred for PCI under treatment with prasugrel 3.75mg/day
- Registration Number
- JPRN-UMIN000017131
- Lead Sponsor
- Kobe University Graduate School of Medicine, Division of Cardiovascular Medicine, Department of Internal Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 250
Inclusion Criteria
Not provided
Exclusion Criteria
1.patient treated with warfarin or novel oral anticoagulants (NOAC) 2.patient treated with other antiplatelet therapy 3.planning an invasive treatment with high bleeding risk 4.contraindication of aspirin or prasugrel
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method